US EditionPublished • loading... • Updated
Wisconsin will get $80 million more from Purdue Pharma settlement
- On Friday, May 1, 2026, Purdue Pharma officially ended operations as part of a $7.4 billion settlement resolving thousands of lawsuits over the company's role in fueling the nationwide opioid crisis.
- Years of litigation and a 2019 bankruptcy filing led to this resolution, which mandates the Sackler family contribute up to $7 billion over 15 years while permanently barring them from selling opioids in the United States.
- Purdue's manufacturing operations transfer to Knoa Pharma LLC, a new public benefit corporation overseen by an independent board barred from marketing opioids and required to release more than 30 million internal documents.
- New Jersey District Judge Madeline Cox Arleo cleared the final legal hurdle Tuesday, enabling settlement funds to support public health responses nationwide with individual victim payments expected to range from about $8,000 to about $16,000.
- Broader settlements worth more than $50 billion aim to address the overdose epidemic across the United States, though the crisis remains linked to hundreds of thousands of deaths since 1999.
Insights by Ground AI
33 Articles
33 Articles
Maryland to Receive Over $90M from Purdue-Sackler Deal
BALTIMORE, Md. — Maryland is set to receive more than $90 million as part of a historic $7.4 billion national settlement with Purdue Pharma and the Sackler family that became effective today, Attorney General Anthony G. Brown announced. The landmark agreement caps nearly a decade of multistate investigations and litigation into Purdue’s and the Sacklers’ roles in the aggressive marketing of opioids that fueled the deadliest drug crisis in U.S. h…
Coverage Details
Total News Sources33
Leaning Left8Leaning Right0Center18Last UpdatedBias Distribution69% Center
Bias Distribution
- 69% of the sources are Center
69% Center
L 31%
C 69%
Factuality
To view factuality data please Upgrade to Premium
